TreeWAS – Variant ID: rs113228472

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
N32.8 Other specified disorders of bladder	0.000	0.864	0.136
N32 Other disorders of bladder	0.000	0.886	0.114
N32.3 Diverticulum of bladder	0.000	0.897	0.103
N32.0 Bladder-neck obstruction	0.000	0.902	0.098
N32.4 Rupture of bladder, nontraumatic	0.000	0.918	0.082
N32.2 Vesical fistula, not elsewhere classified	0.000	0.918	0.082
N32.1 Vesicointestinal fistula	0.000	0.918	0.082
N32.9 Bladder disorder, unspecified	0.000	0.919	0.081
N30-N39 Other diseases of urinary system	0.000	0.962	0.038
N35 Urethral stricture	0.000	0.967	0.033
N30 Cystitis	0.000	0.970	0.030
N35.9 Urethral stricture, unspecified	0.000	0.970	0.030
N30.9 Cystitis, unspecified	0.000	0.971	0.029
N31 Neuromuscular dysfunction of bladder, not elsewhere classified	0.000	0.971	0.029
N37 Urethral disorders in diseases classified elsewhere	0.000	0.972	0.028
N33 Bladder disorders in diseases classified elsewhere	0.000	0.972	0.028
N34 Urethritis and urethral syndrome	0.000	0.973	0.027
N31.8 Other neuromuscular dysfunction of bladder	0.000	0.974	0.026
N35.1 Postinfective urethral stricture, not elsewhere classified	0.000	0.976	0.024
N35.0 Posttraumatic urethral stricture	0.000	0.976	0.024
N30.8 Other cystitis	0.000	0.978	0.022
N35.8 Other urethral stricture	0.000	0.978	0.022
N31.2 Flaccid neuropathic bladder, not elsewhere classified	0.000	0.978	0.022
N30.4 Irradiation cystitis	0.000	0.978	0.022
N36 Other disorders of urethra	0.000	0.978	0.022
N31.1 Reflex neuropathic bladder, not elsewhere classified	0.000	0.979	0.021
N31.0 Uninhibited neuropathic bladder, not elsewhere classified	0.000	0.979	0.021
N30.3 Trigonitis	0.000	0.979	0.021
N33.8 Bladder disorders in other diseases classified elsewhere	0.000	0.980	0.020
N33.0 Tuberculous cystitis	0.000	0.980	0.020
N37.8 Other urethral disorders in diseases classified elsewhere	0.000	0.980	0.020
N37.0 Urethritis in diseases classified elsewhere	0.000	0.980	0.020
N30.1 Interstitial cystitis (chronic)	0.000	0.980	0.020
N34.3 Urethral syndrome, unspecified	0.000	0.980	0.019
N34.1 Nonspecific urethritis	0.000	0.980	0.019
N34.0 Urethral abscess	0.000	0.980	0.019
N34.2 Other urethritis	0.000	0.981	0.018
N36.2 Urethral caruncle	0.000	0.982	0.018
N30.2 Other chronic cystitis	0.000	0.984	0.016
N36.9 Urethral disorder, unspecified	0.000	0.984	0.016
N36.1 Urethral diverticulum	0.000	0.984	0.016
N36.3 Prolapsed urethral mucosa	0.000	0.984	0.015
N30.0 Acute cystitis	0.000	0.985	0.015
N39 Other disorders of urinary system	0.000	0.987	0.013
N36.0 Urethral fistula	0.000	0.988	0.012
N31.9 Neuromuscular dysfunction of bladder, unspecified	0.000	0.988	0.012
N39.4 Other specified urinary incontinence	0.000	0.988	0.012
N36.8 Other specified disorders of urethra	0.000	0.988	0.011
N39.2 Orthostatic proteinuria, unspecified	0.000	0.990	0.009
N39.1 Persistent proteinuria, unspecified	0.000	0.990	0.009
N39.3 Stress incontinence	0.000	0.992	0.008
N39.8 Other specified disorders of urinary system	0.000	0.992	0.008
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)	0.000	0.992	0.008
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.007	0.993	0.000
N39.9 Disorder of urinary system, unspecified	0.000	0.993	0.007
M25.56 Pain in joint (Lower leg)	0.000	0.994	0.006
M13.9 Arthritis, unspecified	0.000	0.994	0.006
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.006	0.994	0.000
D06.9 Cervix, unspecified	0.000	0.994	0.006
M25.57 Pain in joint (Ankle and foot)	0.000	0.994	0.006
M13.99 Arthritis, unspecified (Site unspecified)	0.000	0.994	0.006
M25.5 Pain in joint	0.000	0.995	0.005
K43.9 Ventral hernia without obstruction or gangrene	0.000	0.995	0.005
Z88.2 Personal history of allergy to sulphonamides	0.000	0.995	0.005
Y45.1 Salicylates	0.005	0.995	0.000
M13.96 Arthritis, unspecified (Lower leg)	0.000	0.995	0.005
M25.55 Pain in joint (Pelvic region and thigh)	0.000	0.995	0.005
M13.94 Arthritis, unspecified (Hand)	0.000	0.995	0.005
M13.98 Arthritis, unspecified (Other)	0.000	0.995	0.005
M13.90 Arthritis, unspecified (Multiple sites)	0.000	0.995	0.005
M13.93 Arthritis, unspecified (Forearm)	0.000	0.995	0.005
M13 Other arthritis	0.000	0.995	0.005
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.005	0.995	0.000
M13.97 Arthritis, unspecified (Ankle and foot)	0.000	0.995	0.005
M13.95 Arthritis, unspecified (Pelvic region and thigh)	0.000	0.995	0.005
Z36.9 Antenatal screening, unspecified	0.005	0.995	0.000
Z36 Antenatal screening	0.005	0.995	0.000
M13.92 Arthritis, unspecified (Upper arm)	0.000	0.995	0.005
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.004	0.995	0.000
Y45.8 Other analgesics and antipyretics	0.004	0.995	0.000
Y45.5 4-Aminophenol derivatives	0.004	0.995	0.000
Y45.4 Antirheumatics	0.004	0.995	0.000
Y45.2 Propionic acid derivatives	0.004	0.995	0.000
M25.53 Pain in joint (Forearm)	0.000	0.995	0.005
M25.54 Pain in joint (Hand)	0.000	0.995	0.005
S32.00 Fracture of lumbar vertebra (closed)	0.005	0.995	0.000
Z36.8 Other antenatal screening	0.005	0.995	0.000
M25.59 Pain in joint (Site unspecified)	0.000	0.995	0.004
Z36.0 Antenatal screening for chromosomal anomalies	0.004	0.996	0.000
Y45.0 Opioids and related analgesics	0.004	0.996	0.000
M13.0 Polyarthritis, unspecified	0.000	0.996	0.004
Y43 Primarily systemic agents	0.004	0.996	0.000
M06.9 Rheumatoid arthritis, unspecified	0.000	0.996	0.004
M25.58 Pain in joint (Other)	0.000	0.996	0.004
Y52 Agents primarily affecting the cardiovascular system	0.004	0.996	0.000
Y40 Systemic antibiotics	0.004	0.996	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.004	0.996	0.000
M13.91 Arthritis, unspecified (Shoulder region)	0.000	0.996	0.004
Y42.7 Androgens and anabolic congeners	0.004	0.996	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.004	0.996	0.000
Z36.2 Other antenatal screening based on amniocentesis	0.004	0.996	0.000
M13.00 Polyarthritis, unspecified (Multiple sites)	0.000	0.996	0.004
Z36.1 Antenatal screening for raised alphafetoprotein level	0.004	0.996	0.000
Y57 Other and unspecified drugs and medicaments	0.004	0.996	0.000
M13.8 Other specified arthritis	0.000	0.996	0.004
M13.1 Monoarthritis, not elsewhere classified	0.000	0.996	0.004
M06 Other rheumatoid arthritis	0.000	0.996	0.004
Y43.3 Other antineoplastic drugs	0.004	0.996	0.000
Y59 Other and unspecified vaccines and biological substances	0.004	0.996	0.000
Y58 Bacterial vaccines	0.004	0.996	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.004	0.996	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.004	0.996	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.004	0.996	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.004	0.996	0.000
Y48 Anaesthetics and therapeutic gases	0.004	0.996	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.004	0.996	0.000
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.004	0.996	0.000
M07.39 Other psoriatic arthropathies (Site unspecified)	0.000	0.996	0.004
Y41 Other systemic anti-infectives and antiparasitics	0.004	0.996	0.000
Y44 Agents primarily affecting blood constituents	0.004	0.996	0.000
Z36.5 Antenatal screening for isoimmunisation	0.004	0.996	0.000
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.004	0.996	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.004	0.996	0.000
Y43.0 Antiallergic and antiemetic drugs	0.003	0.996	0.000
N95.0 Postmenopausal bleeding	0.000	0.996	0.004
Y40.0 Penicillins	0.003	0.996	0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.000	0.996	0.003
M25.50 Pain in joint (Multiple sites)	0.000	0.996	0.003
Y40.9 Systemic antibiotic, unspecified	0.003	0.996	0.000
M05-M14 Inflammatory polyarthropathies	0.000	0.996	0.004
Y49.5 Other antipsychotics and neuroleptics	0.003	0.996	0.000
M25.52 Pain in joint (Upper arm)	0.000	0.996	0.003
S32.0 Fracture of lumbar vertebra	0.003	0.996	0.000
I26.9 Pulmonary embolism without mention of acute cor pulmonale	0.000	0.997	0.003
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.003	0.997	0.000
M13.09 Polyarthritis, unspecified (Site unspecified)	0.000	0.997	0.003
M13.08 Polyarthritis, unspecified (Other)	0.000	0.997	0.003
M13.07 Polyarthritis, unspecified (Ankle and foot)	0.000	0.997	0.003
M13.06 Polyarthritis, unspecified (Lower leg)	0.000	0.997	0.003
M13.05 Polyarthritis, unspecified (Pelvic region and thigh)	0.000	0.997	0.003
M13.04 Polyarthritis, unspecified (Hand)	0.000	0.997	0.003
M13.03 Polyarthritis, unspecified (Forearm)	0.000	0.997	0.003
M13.02 Polyarthritis, unspecified (Upper arm)	0.000	0.997	0.003
M13.01 Polyarthritis, unspecified (Shoulder region)	0.000	0.997	0.003
Y51 Drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.000	0.997	0.003
M07 Psoriatic and enteropathic arthropathies	0.000	0.997	0.003
Y43.9 Primarily systemic agent, unspecified	0.003	0.997	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.003	0.997	0.000
Y43.6 Enzymes, not elsewhere classified	0.003	0.997	0.000
Y43.5 Acidifying and alkalising agents	0.003	0.997	0.000
Y43.2 Antineoplastic natural products	0.003	0.997	0.000
Y43.1 Antineoplastic antimetabolites	0.003	0.997	0.000
Y57.8 Other drugs and medicaments	0.003	0.997	0.000
M07.3 Other psoriatic arthropathies	0.000	0.997	0.003
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.000	0.997	0.003
Y52.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
M06.98 Rheumatoid arthritis, unspecified (Other)	0.000	0.997	0.003
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.000	0.997	0.003
Y46.4 Iminostilbenes	0.003	0.997	0.000
Y43.4 Immunosuppressive agents	0.003	0.997	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.997	0.000
Y40.7 Antifungal antibiotics, systemically used	0.003	0.997	0.000
Y40.6 Rifamycins	0.003	0.997	0.000
Y40.5 Aminoglycosides	0.003	0.997	0.000
Y40.4 Tetracyclines	0.003	0.997	0.000
Y40.3 Macrolides	0.003	0.997	0.000
Y40.2 Chloramphenicol group	0.003	0.997	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.003	0.997	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
Y52.7 Peripheral vasodilators	0.003	0.997	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
Y52.1 Calcium-channel blockers	0.003	0.997	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
Y49.9 Psychotropic drug, unspecified	0.003	0.997	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
Y49.7 Psychostimulants with abuse potential	0.003	0.997	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.003	0.997	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.997	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.003	0.997	0.000
Y49.2 Other and unspecified antidepressants	0.003	0.997	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.997	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.003	0.997	0.000
M06.0 Seronegative rheumatoid arthritis	0.000	0.997	0.003
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
Y57.5 X-ray contrast media	0.003	0.997	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.997	0.000
Y42.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
Y42.4 Oral contraceptives	0.003	0.997	0.000
Y42.2 Antithyroid drugs	0.003	0.997	0.000
Y42.1 Thyroid hormones and substitutes	0.003	0.997	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.003	0.997	0.000
Y46.8 Antispasticity drugs	0.003	0.997	0.000
Y46.7 Anti-Parkinsonism drugs	0.003	0.997	0.000
Y46.6 Other and unspecified antiepileptics	0.003	0.997	0.000
Y46.5 Valproic acid	0.003	0.997	0.000
Y46.3 Deoxybarbiturates	0.003	0.997	0.000
Y46.2 Hydantoin derivatives	0.003	0.997	0.000
Y46.1 Oxazolidinediones	0.003	0.997	0.000
Y46.0 Succinimides	0.003	0.997	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
N95.1 Menopausal and female climacteric states	0.000	0.997	0.003
N95.8 Other specified menopausal and perimenopausal disorders	0.000	0.997	0.003
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.000	0.997	0.003
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.000	0.997	0.003
Y57.7 Vitamins, not elsewhere classified	0.003	0.997	0.000
Y57.6 Other diagnostic agents	0.003	0.997	0.000
Y57.4 Pharmaceutical excipients	0.003	0.997	0.000
Y57.3 Alcohol deterrents	0.003	0.997	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
Y57.1 Lipotropic drugs	0.003	0.997	0.000
Y57.0 Appetite depressants [anorectics]	0.003	0.997	0.000
M13.19 Monoarthritis, not elsewhere classified (Site unspecified)	0.000	0.997	0.003
M13.18 Monoarthritis, not elsewhere classified (Other)	0.000	0.997	0.003
M13.17 Monoarthritis, not elsewhere classified (Ankle and foot)	0.000	0.997	0.003
M13.16 Monoarthritis, not elsewhere classified (Lower leg)	0.000	0.997	0.003
M13.15 Monoarthritis, not elsewhere classified (Pelvic region and thigh)	0.000	0.997	0.003
M13.14 Monoarthritis, not elsewhere classified (Hand)	0.000	0.997	0.003
M13.13 Monoarthritis, not elsewhere classified (Forearm)	0.000	0.997	0.003
M13.12 Monoarthritis, not elsewhere classified (Upper arm)	0.000	0.997	0.003
M13.11 Monoarthritis, not elsewhere classified (Shoulder region)	0.000	0.997	0.003
M13.10 Monoarthritis, not elsewhere classified (Multiple sites)	0.000	0.997	0.003
M13.89 Other specified arthritis (Site unspecified)	0.000	0.997	0.003
M13.88 Other specified arthritis (Other)	0.000	0.997	0.003
M13.87 Other specified arthritis (Ankle and foot)	0.000	0.997	0.003
M13.86 Other specified arthritis (Lower leg)	0.000	0.997	0.003
M13.85 Other specified arthritis (Pelvic region and thigh)	0.000	0.997	0.003
M13.84 Other specified arthritis (Hand)	0.000	0.997	0.003
M13.83 Other specified arthritis (Forearm)	0.000	0.997	0.003
M13.82 Other specified arthritis (Upper arm)	0.000	0.997	0.003
M13.81 Other specified arthritis (Shoulder region)	0.000	0.997	0.003
M13.80 Other specified arthritis (Multiple sites)	0.000	0.997	0.003
M06.8 Other specified rheumatoid arthritis	0.000	0.997	0.003
M06.2 Rheumatoid bursitis	0.000	0.997	0.003
M06.1 Adult-onset Still's disease	0.000	0.997	0.003
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.003	0.997	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.003	0.997	0.000
Y47.4 Bromine compounds	0.003	0.997	0.000
Y47.3 Paraldehyde	0.003	0.997	0.000
Y47.2 Chloral derivatives	0.003	0.997	0.000
Y47.1 Benzodiazepines	0.003	0.997	0.000
Y47.0 Barbiturates, not elsewhere classified	0.003	0.997	0.000
Y48.5 Therapeutic gases	0.003	0.997	0.000
Y48.4 Anaesthetic, unspecified	0.003	0.997	0.000
Y48.3 Local anaesthetics	0.003	0.997	0.000
Y48.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
Y48.1 Parenteral anaesthetics	0.003	0.997	0.000
Y48.0 Inhaled anaesthetics	0.003	0.997	0.000
Y50.9 Central nervous system stimulant, unspecified	0.003	0.997	0.000
Y50.8 Other central nervous system stimulants	0.003	0.997	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.003	0.997	0.000
Y50.1 Opioid receptor antagonists	0.003	0.997	0.000
Y50.0 Analeptics	0.003	0.997	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
Y53.7 Emetics	0.003	0.997	0.000
Y53.6 Antidiarrhoeal drugs	0.003	0.997	0.000
Y53.5 Digestants	0.003	0.997	0.000
Y53.4 Other laxatives	0.003	0.997	0.000
Y53.3 Saline and osmotic laxatives	0.003	0.997	0.000
Y53.2 Stimulant laxatives	0.003	0.997	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
Y53.0 Histamine H2-receptor antagonists	0.003	0.997	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.997	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.003	0.997	0.000
Y55.5 Anticommon cold drugs	0.003	0.997	0.000
Y55.4 Expectorants	0.003	0.997	0.000
Y55.3 Antitussives	0.003	0.997	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.003	0.997	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.997	0.000
Y55.0 Oxytocic drugs	0.003	0.997	0.000
Y56.9 Topical agent, unspecified	0.003	0.997	0.000
Y56.8 Other topical agents	0.003	0.997	0.000
Y56.7 Dental drugs, topically applied	0.003	0.997	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
Y56.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
Y56.3 Emollients, demulcents and protectants	0.003	0.997	0.000
Y56.2 Local astringents and local detergents	0.003	0.997	0.000
Y56.1 Antipruritics	0.003	0.997	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.997	0.000
Y58.9 Other and unspecified bacterial vaccines	0.003	0.997	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.003	0.997	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.003	0.997	0.000
Y58.5 Diphtheria vaccine	0.003	0.997	0.000
Y58.4 Tetanus vaccine	0.003	0.997	0.000
Y58.3 Plague vaccine	0.003	0.997	0.000
Y58.2 Cholera vaccine	0.003	0.997	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.003	0.997	0.000
Y58.0 BCG vaccine	0.003	0.997	0.000
Y59.9 Vaccine or biological substance, unspecified	0.003	0.997	0.000
Y59.8 Other specified vaccines and biological substances	0.003	0.997	0.000
Y59.3 Immunoglobulin	0.003	0.997	0.000
Y59.2 Protozoal vaccines	0.003	0.997	0.000
Y59.1 Rickettsial vaccines	0.003	0.997	0.000
Y59.0 Viral vaccines	0.003	0.997	0.000
M06.4 Inflammatory polyarthropathy	0.000	0.997	0.003
D06 Carcinoma in situ of cervix uteri	0.000	0.997	0.003
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.997	0.000
Y41.5 Antiviral drugs	0.003	0.997	0.000
Y41.4 Anthelminthics	0.003	0.997	0.000
Y41.3 Other antiprotozoal drugs	0.003	0.997	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.997	0.000
Y41.1 Antimycobacterial drugs	0.003	0.997	0.000
Y41.0 Sulphonamides	0.003	0.997	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.003	0.997	0.000
Y44.7 Plasma substitutes	0.003	0.997	0.000
Y44.6 Natural blood and blood products	0.003	0.997	0.000
Y44.5 Thrombolytic drugs	0.003	0.997	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.003	0.997	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.997	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.003	0.997	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.003	0.997	0.000
M11 Other crystal arthropathies	0.000	0.997	0.003
N95 Menopausal and other perimenopausal disorders	0.000	0.997	0.003
M14 Arthropathies in other diseases classified elsewhere	0.000	0.997	0.003
M12 Other specific arthropathies	0.000	0.997	0.003
M09 Juvenile arthritis in diseases classified elsewhere	0.000	0.997	0.003
M08 Juvenile arthritis	0.000	0.997	0.003
K58.9 Irritable bowel syndrome without diarrhoea	0.000	0.997	0.003
M06.3 Rheumatoid nodule	0.000	0.997	0.003
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
S32.01 Fracture of lumbar vertebra (open)	0.003	0.997	0.000
Y40.8 Other systemic antibiotics	0.003	0.997	0.000
Y44.2 Anticoagulants	0.003	0.997	0.000
Y54.9 Mineral salts, not elsewhere classified	0.003	0.997	0.000
Y54.8 Agents affecting uric acid metabolism	0.003	0.997	0.000
Y54.7 Agents affecting calcification	0.003	0.997	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.003	0.997	0.000
Y54.5 Other diuretics	0.003	0.997	0.000
Y54.4 Loop [high-ceiling] diuretics	0.003	0.997	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.003	0.997	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.003	0.997	0.000
Y54.0 Mineralocorticoids	0.003	0.997	0.000
M07.6 Other enteropathic arthropathies	0.000	0.997	0.002
M07.5 Arthropathy in ulcerative colitis	0.000	0.997	0.002
M07.4 Arthropathy in Crohn's disease [regional enteritis]	0.000	0.997	0.002
M07.2 Psoriatic spondylitis	0.000	0.997	0.002
M07.1 Arthritis mutilans	0.000	0.997	0.002
M07.0 Distal interphalangeal psoriatic arthropathy	0.000	0.997	0.002
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.002	0.997	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.997	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.997	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.997	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.997	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.002	0.997	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.997	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.002	0.997	0.000
Y51.0 Anticholinesterase agents	0.002	0.997	0.000
S32 Fracture of lumbar spine and pelvis	0.003	0.997	0.000
M06.00 Seronegative rheumatoid arthritis (Multiple sites)	0.000	0.997	0.003
M07.38 Other psoriatic arthropathies (Other)	0.000	0.997	0.002
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.000	0.997	0.002
M07.36 Other psoriatic arthropathies (Lower leg)	0.000	0.997	0.002
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.000	0.997	0.002
M07.34 Other psoriatic arthropathies (Hand)	0.000	0.997	0.002
M07.33 Other psoriatic arthropathies (Forearm)	0.000	0.997	0.002
M07.32 Other psoriatic arthropathies (Upper arm)	0.000	0.997	0.002
M07.31 Other psoriatic arthropathies (Shoulder region)	0.000	0.997	0.002
Y57.9 Drug or medicament, unspecified	0.002	0.997	0.000
M05 Seropositive rheumatoid arthritis	0.000	0.997	0.003
M06.09 Seronegative rheumatoid arthritis (Site unspecified)	0.000	0.997	0.003
M25.51 Pain in joint (Shoulder region)	0.000	0.997	0.003
M06.08 Seronegative rheumatoid arthritis (Other)	0.000	0.997	0.002
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)	0.000	0.997	0.002
M06.06 Seronegative rheumatoid arthritis (Lower leg)	0.000	0.997	0.002
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)	0.000	0.997	0.002
M06.04 Seronegative rheumatoid arthritis (Hand)	0.000	0.997	0.002
M06.03 Seronegative rheumatoid arthritis (Forearm)	0.000	0.997	0.002
M06.02 Seronegative rheumatoid arthritis (Upper arm)	0.000	0.997	0.002
M06.01 Seronegative rheumatoid arthritis (Shoulder region)	0.000	0.997	0.002
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.000	0.997	0.002
S92.00 Fracture of calcaneus (closed)	0.002	0.997	0.000
K43 Ventral hernia	0.000	0.997	0.002
S22.40 Multiple fractures of ribs (closed)	0.002	0.998	0.000
Y54.3 Benzothiadiazine derivatives	0.002	0.998	0.000
M06.19 Adult-onset Still's disease (Site unspecified)	0.000	0.998	0.002
M06.18 Adult-onset Still's disease (Other)	0.000	0.998	0.002
M06.17 Adult-onset Still's disease (Ankle and foot)	0.000	0.998	0.002
M06.16 Adult-onset Still's disease (Lower leg)	0.000	0.998	0.002
M06.15 Adult-onset Still's disease (Pelvic region and thigh)	0.000	0.998	0.002
M06.14 Adult-onset Still's disease (Hand)	0.000	0.998	0.002
M06.13 Adult-onset Still's disease (Forearm)	0.000	0.998	0.002
M06.12 Adult-onset Still's disease (Upper arm)	0.000	0.998	0.002
M06.11 Adult-onset Still's disease (Shoulder region)	0.000	0.998	0.002
M06.10 Adult-onset Still's disease (Multiple sites)	0.000	0.998	0.002
M06.29 Rheumatoid bursitis (Site unspecified)	0.000	0.998	0.002
M06.28 Rheumatoid bursitis (Other)	0.000	0.998	0.002
M06.27 Rheumatoid bursitis (Ankle and foot)	0.000	0.998	0.002
M06.26 Rheumatoid bursitis (Lower leg)	0.000	0.998	0.002
M06.25 Rheumatoid bursitis (Pelvic region and thigh)	0.000	0.998	0.002
M06.24 Rheumatoid bursitis (Hand)	0.000	0.998	0.002
M06.23 Rheumatoid bursitis (Forearm)	0.000	0.998	0.002
M06.22 Rheumatoid bursitis (Upper arm)	0.000	0.998	0.002
M06.21 Rheumatoid bursitis (Shoulder region)	0.000	0.998	0.002
M06.20 Rheumatoid bursitis (Multiple sites)	0.000	0.998	0.002
M06.89 Other specified rheumatoid arthritis (Site unspecified)	0.000	0.998	0.002
M06.88 Other specified rheumatoid arthritis (Other)	0.000	0.998	0.002
M06.87 Other specified rheumatoid arthritis (Ankle and foot)	0.000	0.998	0.002
M06.86 Other specified rheumatoid arthritis (Lower leg)	0.000	0.998	0.002
M06.85 Other specified rheumatoid arthritis (Pelvic region and thigh)	0.000	0.998	0.002
M06.84 Other specified rheumatoid arthritis (Hand)	0.000	0.998	0.002
M06.83 Other specified rheumatoid arthritis (Forearm)	0.000	0.998	0.002
M06.82 Other specified rheumatoid arthritis (Upper arm)	0.000	0.998	0.002
M06.81 Other specified rheumatoid arthritis (Shoulder region)	0.000	0.998	0.002
M06.80 Other specified rheumatoid arthritis (Multiple sites)	0.000	0.998	0.002
M11.2 Other chondrocalcinosis	0.000	0.998	0.002
S32.7 Multiple fractures of lumbar spine and pelvis	0.002	0.998	0.000
S32.4 Fracture of acetabulum	0.002	0.998	0.000
M06.48 Inflammatory polyarthropathy (Other)	0.000	0.998	0.002
M06.47 Inflammatory polyarthropathy (Ankle and foot)	0.000	0.998	0.002
M06.46 Inflammatory polyarthropathy (Lower leg)	0.000	0.998	0.002
M06.45 Inflammatory polyarthropathy (Pelvic region and thigh)	0.000	0.998	0.002
M06.44 Inflammatory polyarthropathy (Hand)	0.000	0.998	0.002
M06.43 Inflammatory polyarthropathy (Forearm)	0.000	0.998	0.002
M06.42 Inflammatory polyarthropathy (Upper arm)	0.000	0.998	0.002
M06.41 Inflammatory polyarthropathy (Shoulder region)	0.000	0.998	0.002
M06.40 Inflammatory polyarthropathy (Multiple sites)	0.000	0.998	0.002
D06.7 Other parts of cervix	0.000	0.998	0.002
D06.1 Exocervix	0.000	0.998	0.002
D06.0 Endocervix	0.000	0.998	0.002
S32.1 Fracture of sacrum	0.002	0.998	0.000
M06.49 Inflammatory polyarthropathy (Site unspecified)	0.000	0.998	0.002
M11.9 Crystal arthropathy, unspecified	0.000	0.998	0.002
M11.8 Other specified crystal arthropathies	0.000	0.998	0.002
M11.1 Familial chondrocalcinosis	0.000	0.998	0.002
M11.0 Hydroxyapatite deposition disease	0.000	0.998	0.002
N95.9 Menopausal and perimenopausal disorder, unspecified	0.000	0.998	0.002
N95.3 States associated with artificial menopause	0.000	0.998	0.002
M08.9 Juvenile arthritis, unspecified	0.000	0.998	0.002
M08.8 Other juvenile arthritis	0.000	0.998	0.002
M08.4 Pauciarticular juvenile arthritis	0.000	0.998	0.002
M08.3 Juvenile polyarthritis (seronegative)	0.000	0.998	0.002
M08.2 Juvenile arthritis with systemic onset	0.000	0.998	0.002
M08.1 Juvenile ankylosing spondylitis	0.000	0.998	0.002
M08.0 Juvenile rheumatoid arthritis	0.000	0.998	0.002
M09.8 Juvenile arthritis in other diseases classified elsewhere	0.000	0.998	0.002
M09.2 Juvenile arthritis in ulcerative colitis	0.000	0.998	0.002
M09.1 Juvenile arthritis in Crohn's disease [regional enteritis]	0.000	0.998	0.002
M09.0 Juvenile arthritis in psoriasis	0.000	0.998	0.002
M12.8 Other specific arthropathies, not elsewhere classified	0.000	0.998	0.002
M12.5 Traumatic arthropathy	0.000	0.998	0.002
M12.4 Intermittent hydrarthrosis	0.000	0.998	0.002
M12.3 Palindromic rheumatism	0.000	0.998	0.002
M12.2 Villonodular synovitis (pigmented)	0.000	0.998	0.002
M12.1 Kaschin-Beck disease	0.000	0.998	0.002
M12.0 Chronic postrheumatic arthropathy [Jaccoud]	0.000	0.998	0.002
M14.8 Arthropathies in other specified diseases classified elsewhere	0.000	0.998	0.002
M14.6 Neuropathic arthropathy	0.000	0.998	0.002
M14.5 Arthropathies in other endocrine, nutritional and metabolic disorders	0.000	0.998	0.002
M14.4 Arthropathy in amyloidosis	0.000	0.998	0.002
M14.3 Lipoid dermatoarthritis	0.000	0.998	0.002
M14.2 Diabetic arthropathy	0.000	0.998	0.002
M14.1 Crystal arthropathy in other metabolic disorders	0.000	0.998	0.002
M14.0 Gouty arthropathy due to enzyme defects and other inherited disorders	0.000	0.998	0.002
M06.39 Rheumatoid nodule (Site unspecified)	0.000	0.998	0.002
M06.38 Rheumatoid nodule (Other)	0.000	0.998	0.002
M06.37 Rheumatoid nodule (Ankle and foot)	0.000	0.998	0.002
M06.36 Rheumatoid nodule (Lower leg)	0.000	0.998	0.002
M06.35 Rheumatoid nodule (Pelvic region and thigh)	0.000	0.998	0.002
M06.33 Rheumatoid nodule (Forearm)	0.000	0.998	0.002
M06.32 Rheumatoid nodule (Upper arm)	0.000	0.998	0.002
M06.31 Rheumatoid nodule (Shoulder region)	0.000	0.998	0.002
M06.30 Rheumatoid nodule (Multiple sites)	0.000	0.998	0.002
F20.9 Schizophrenia, unspecified	0.002	0.998	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
M07.30 Other psoriatic arthropathies (Multiple sites)	0.000	0.998	0.002
S32.70 Multiple fractures of lumbar spine and pelvis (closed)	0.002	0.998	0.000
M07.09 Distal interphalangeal psoriatic arthropathy (Site unspecified)	0.000	0.998	0.002
M07.08 Distal interphalangeal proriatic arthropathy-Other	0.000	0.998	0.002
M07.07 Distal interphalangeal psoriatic arthropathy (Ankle and foot)	0.000	0.998	0.002
M07.06 Distal interphalangeal proriatic arthropathy-Lower leg	0.000	0.998	0.002
M07.05 Distal interphalangeal proriatic arthropathy-Pelvic/thigh	0.000	0.998	0.002
M07.04 Distal interphalangeal psoriatic arthropathy (Hand)	0.000	0.998	0.002
M07.03 Distal interphalangeal proriatic arthropathy-Forearm	0.000	0.998	0.002
M07.02 Distal interphalangeal proriatic arthropathy-Upper arm	0.000	0.998	0.002
M07.01 Distal interphalangeal proriatic arthropathy-Shldr region	0.000	0.998	0.002
M07.00 Distal interphalangeal psoriatic arthropathy (Multiple sites)	0.000	0.998	0.002
M07.19 Arthritis mutilans (Site unspecified)	0.000	0.998	0.002
M07.18 Arthritis mutilans (Other)	0.000	0.998	0.002
M07.17 Arthritis mutilans (Ankle and foot)	0.000	0.998	0.002
M07.16 Arthritis mutilans (Lower leg)	0.000	0.998	0.002
M07.15 Arthritis mutilans (Pelvic region and thigh)	0.000	0.998	0.002
M07.14 Arthritis mutilans (Hand)	0.000	0.998	0.002
M07.13 Arthritis mutilans (Forearm)	0.000	0.998	0.002
M07.12 Arthritis mutilans (Upper arm)	0.000	0.998	0.002
M07.11 Arthritis mutilans (Shoulder region)	0.000	0.998	0.002
M07.10 Arthritis mutilans (Multiple sites)	0.000	0.998	0.002
M07.29 Psoriatic spondylitis (Site unspecified)	0.000	0.998	0.002
M07.28 Psoriatic spondylitis (Other)	0.000	0.998	0.002
M07.27 Psoriatic spondylitis (Ankle and foot)	0.000	0.998	0.002
M07.26 Psoriatic spondylitis (Lower leg)	0.000	0.998	0.002
M07.25 Psoriatic spondylitis (Pelvic region and thigh)	0.000	0.998	0.002
M07.24 Psoriatic spondylitis (Hand)	0.000	0.998	0.002
M07.23 Psoriatic spondylitis (Forearm)	0.000	0.998	0.002
M07.22 Psoriatic spondylitis (Upper arm)	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations